The role of ataluren in the treatment of ambulatory and non-ambulatory children with nonsense mutation duchenne muscular dystrophy - a consensus derived using a modified Delphi methodology in Eastern Europe, Greece, Israel and Sweden

Abstract Background This paper details the results of an evaluation of the level of consensus amongst clinicians on the use of ataluren in both ambulatory and non-ambulatory patients with nonsense mutation Duchenne muscular dystrophy (nmDMD). The consensus was derived using a modified Delphi methodo...

Full description

Bibliographic Details
Main Authors: Tanja Golli, Lenka Juříková, Thomas Sejersen, Craig Dixon
Format: Article
Language:English
Published: BMC 2024-02-01
Series:BMC Neurology
Subjects:
Online Access:https://doi.org/10.1186/s12883-024-03570-x